Medical Radiology and Radiation Safety. 2013. Vol. 58. No. 5. P. 54-58
NUCLEAR MEDICINE
D.K. Fomin, O.O. Lyugiy, O.B. Tararuchina
Experience of SPECT/CT Research in the Evaluation of Disease Prevalence in Patients with Differentiated Thyroid Cancer and Planning Further Tactics of Treatment
Russian Scientific Center of Roentgenology and Radiology. Moscow, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: To study the diagnostic efficiency of SPEД/CT in disease prevalence assessment in patients with differentiated thyroid cancer and planning further tactics of treatment.
Material and methods: 20 patients have been examined. All of them had been operated and have being treated with 131I. 18 patients suffered with papillary cancer and 2 patients suffered with follicular thyroid cancer. The age of patients varied from 20 to 73, the group examined consisted of 5 men and 15 women. The research has been carried out on composite SPEД/CT Philips Precedence system.
Results: The results of SPEД/CT and planar scintiscanning revealed full coincidence in 11 cases. There were no such coincidence in other 9 cases.
Conclusion: Carrying out controlling radionuclide examination after 131I treatment is absolutely obliged. It helps in disease prevalence assessment and chose adequate treatment tactics. Carrying out combined SPECT/CT examination leads to modification of treatment in 38 % of patients.
Key words: combined SPECT/CT, differentiated thyroid cancer, whole body planar scintygraphy with 131I